Peer-reviewedPublisher termsRSC Medicinal Chemistry
Recent advances in scaffold-based KRASG12C inhibitors: SAR and biological evaluation insights
- 1Chitkara College of Pharmacy, Chitkara University Rajpura 140401 Punjab India
Related
- Design, Synthesis, and Biological Evaluation of Novel Dithiocarbamate-Based Human Carbonic Anhydrase IX/XII Inhibitors as Potential Anti-Glioblastoma Agents
- Novel Quinoxaline-Based Cyanocarbonimidodithioate Derivatives as Non-Hydroxamate Selective HDAC8 Inhibitors: Design, Synthesis, Biological Evaluation and Mechanistic Studies
- Discovery of Novel HDAC8 Inhibitors Through Shape-Based Virtual Screening: Experimental Validation and Characterization of a Promising Quinoline-Based Hit Scaffold
- PAD4-DB: A Curated Structure–Activity Resource Reveals Hub-Organized Activity Cliffs and Scaffold-Dependent SAR Ruggedness in PAD4 Inhibitors
- Untargeted screening of drug-like compounds using high-throughput metabolomics uncovers inhibitors of key biological pathways
BibTeX
@article{bhattacharjee2026recent,
title = {{Recent advances in scaffold-based KRASG12C inhibitors: SAR and biological evaluation insights}},
author = {Tomojit Bhattacharjee and Ankush Kumar and Thakur Gurjeet Singh and Rohit Bhatia},
journal = {RSC Medicinal Chemistry},
year = {2026},
month = oct,
doi = {10.1039/d6md00337k},
url = {https://doi.org/10.1039/d6md00337k},
}
RIS
TY - JOUR
TI - Recent advances in scaffold-based KRASG12C inhibitors: SAR and biological evaluation insights
AU - Tomojit Bhattacharjee
AU - Ankush Kumar
AU - Thakur Gurjeet Singh
AU - Rohit Bhatia
PY - 2026
DA - 2026/10/26
JO - RSC Medicinal Chemistry
DO - 10.1039/d6md00337k
UR - https://doi.org/10.1039/d6md00337k
SN - 2632-8682
ER -